Efficacy and safety of vonoprazan–amoxicillin dual therapy for first-line treatment: a single-center, randomized, controlled trial
Background: With the increase in antibiotic resistance, the success rate of Helicobacter pylori ( H. pylori ) eradication therapy has declined in recent years. Vonoprazan–amoxicillin (VA) dual therapy has been reported to be a promising regimen. Objectives: To compare the efficacy and safety of VA d...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2023-08-01
|
| Series: | Therapeutic Advances in Gastroenterology |
| Online Access: | https://doi.org/10.1177/17562848231190976 |